DRMAW vs PODD
Dermata Therapeutics Inc. Warrant (DRMAW) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
DRMAW does not have a complete income-statement cache yet.
Latest reported PODD revenue for 2026-06-30 was $1.56B. Net income was $186.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
DRMAW currently screens at market cap $0. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the DRMAW and PODD stock pages for the full models.
Not investment advice.